Literature DB >> 23445063

The role of collagen synthesis in ventricular and vascular adaptation to hypoxic pulmonary hypertension.

David Schreier1, Timothy Hacker, Gouqing Song, Naomi Chesler.   

Abstract

Pulmonary arterial hypertension (PAH) is a rapidly fatal disease in which mortality is typically due to right ventricular (RV) failure. An excellent predictor of mortality in PAH is proximal pulmonary artery stiffening, which is mediated by collagen accumulation in hypoxia-induced pulmonary hypertension (HPH) in mice. We sought to investigate the impact of limiting vascular and ventricular collagen accumulation on RV function and the hemodynamic coupling efficiency between the RV and pulmonary vasculature. Inbred mice were exposed to chronic hypoxia for 10 days with either no treatment (HPH) or with treatment with a proline analog that impairs collagen synthesis (CHOP-PEG; HPH + CP). Both groups were compared to control mice (CTL) exposed only to normoxia (no treatment). An admittance catheter was used to measure pressure-volume loops at baseline and during vena cava occlusion, with mice ventilated with either room air or 8% oxygen, from which pulmonary hemodynamics, RV function, and ventricular-vascular coupling efficiency (ηvvc) were calculated. Proline analog treatment limited increases in RV afterload (neither effective arterial elastance Ea nor total pulmonary vascular resistance significantly increased compared to CTL with CHOP-PEG), limited the development of pulmonary hypertension (CHOP-PEG reduced right ventricular systolic pressure by 10% compared to HPH, p < 0.05), and limited RV hypertrophy (CHOP-PEG reduced RV mass by 18% compared to HPH, p < 0.005). In an acutely hypoxic state, treatment improved RV function (CHOP-PEG increased end-systolic elastance Ees by 43%, p < 0.05) and maintained ηvvc at control, room air levels. CHOP-PEG also decreased lung collagen content by 12% measured biochemically compared to HPH (p < 0.01), with differences evident in large and small pulmonary arteries by histology. Our results demonstrate that preventing new collagen synthesis limits pulmonary hypertension development by reducing collagen accumulation in the pulmonary arteries that affect RV afterload. In particular, the proline analog limited structural and functional changes in distal pulmonary arteries in this model of early and somewhat mild pulmonary hypertension. We conclude that collagen plays an important role in small pulmonary artery remodeling and, thereby, affects RV structure and function changes induced by chronic hypoxia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23445063      PMCID: PMC3705819          DOI: 10.1115/1.4023480

Source DB:  PubMed          Journal:  J Biomech Eng        ISSN: 0148-0731            Impact factor:   2.097


  33 in total

Review 1.  A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.

Authors:  Jose Gomez-Arroyo; Sheinei J Saleem; Shiro Mizuno; Aamer A Syed; Harm J Bogaard; Antonio Abbate; Laimute Taraseviciene-Stewart; Yon Sung; Donatas Kraskauskas; Daniela Farkas; Daniel H Conrad; Mark R Nicolls; Norbert F Voelkel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-03       Impact factor: 5.464

Review 2.  Primary pulmonary hypertension.

Authors:  L J Rubin
Journal:  N Engl J Med       Date:  1997-01-09       Impact factor: 91.245

3.  Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension.

Authors:  V S Nikam; R T Schermuly; R Dumitrascu; N Weissmann; G Kwapiszewska; N Morrell; W Klepetko; L Fink; W Seeger; R Voswinckel
Journal:  Eur Respir J       Date:  2010-06-04       Impact factor: 16.671

Review 4.  Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies.

Authors:  Bianca C Bernardo; Kate L Weeks; Lynette Pretorius; Julie R McMullen
Journal:  Pharmacol Ther       Date:  2010-05-12       Impact factor: 12.310

5.  Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.

Authors:  Marc Humbert; Olivier Sitbon; Ari Chaouat; Michèle Bertocchi; Gilbert Habib; Virginie Gressin; Azzedine Yaïci; Emmanuel Weitzenblum; Jean-François Cordier; François Chabot; Claire Dromer; Christophe Pison; Martine Reynaud-Gaubert; Alain Haloun; Marcel Laurent; Eric Hachulla; Vincent Cottin; Bruno Degano; Xavier Jaïs; David Montani; Rogério Souza; Gérald Simonneau
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

6.  Neonatal calves develop airflow limitation due to chronic hypobaric hypoxia.

Authors:  S C Inscore; K R Stenmark; C Orton; C G Irvin
Journal:  J Appl Physiol (1985)       Date:  1991-01

7.  Determination of right ventricular structure and function in normoxic and hypoxic mice: a transesophageal echocardiographic study.

Authors:  M Scherrer-Crosbie; W Steudel; P R Hunziker; G P Foster; L Garrido; N Liel-Cohen; W M Zapol; M H Picard
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

8.  Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension.

Authors:  Cristhiaan D Ochoa; Lunyin Yu; Essam Al-Ansari; Charles A Hales; Deborah A Quinn
Journal:  J Cardiothorac Surg       Date:  2010-05-04       Impact factor: 1.637

9.  Pulmonary hypertension in TNF-alpha-overexpressing mice is associated with decreased VEGF gene expression.

Authors:  Masaki Fujita; Robert J Mason; Carleyne Cool; John M Shannon; Nobuyuki Hara; Karen A Fagan
Journal:  J Appl Physiol (1985)       Date:  2002-08-09

10.  Pulmonary vascular wall stiffness: An important contributor to the increased right ventricular afterload with pulmonary hypertension.

Authors:  Zhijie Wang; Naomi C Chesler
Journal:  Pulm Circ       Date:  2011 Apr-Jun       Impact factor: 3.017

View more
  23 in total

1.  Transglutaminase 2 in pulmonary and cardiac tissue remodeling in experimental pulmonary hypertension.

Authors:  Krishna C Penumatsa; Deniz Toksoz; Rod R Warburton; Mousa Kharnaf; Ioana R Preston; Navin K Kapur; Chaitan Khosla; Nicholas S Hill; Barry L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-03       Impact factor: 5.464

2.  Multiscale structure-function relationships in right ventricular failure due to pressure overload.

Authors:  Tik-Chee Cheng; Jennifer L Philip; Diana M Tabima; Timothy A Hacker; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-08       Impact factor: 4.733

3.  Patient-specific computational modeling of blood flow in the pulmonary arterial circulation.

Authors:  Vitaly O Kheyfets; Lourdes Rios; Triston Smith; Theodore Schroeder; Jeffrey Mueller; Srinivas Murali; David Lasorda; Anthony Zikos; Jennifer Spotti; John J Reilly; Ender A Finol
Journal:  Comput Methods Programs Biomed       Date:  2015-04-28       Impact factor: 5.428

4.  Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.

Authors:  Jennifer L Philip; Thomas M Murphy; David A Schreier; Sydney Stevens; Diana M Tabima; Margie Albrecht; Andrea L Frump; Timothy A Hacker; Tim Lahm; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-15       Impact factor: 4.733

5.  Mutual promotion of FGF21 and PPARγ attenuates hypoxia-induced pulmonary hypertension.

Authors:  Gexiang Cai; Jingjing Liu; Meibin Wang; Lihuang Su; Mengsi Cai; Kate Huang; Xiuchun Li; Manxiang Li; Liangxing Wang; Xiaoying Huang
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-02

6.  Mitochondria DNA mutations cause sex-dependent development of hypertension and alterations in cardiovascular function.

Authors:  Mark J Golob; Lian Tian; Zhijie Wang; Todd A Zimmerman; Christine A Caneba; Timothy A Hacker; Guoqing Song; Naomi C Chesler
Journal:  J Biomech       Date:  2014-12-31       Impact factor: 2.712

7.  TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction.

Authors:  Natasha M Rogers; Maryam Sharifi-Sanjani; Mingyi Yao; Kedar Ghimire; Raquel Bienes-Martinez; Stephanie M Mutchler; Heather E Knupp; Jeffrey Baust; Enrico M Novelli; Mark Ross; Claudette St Croix; Johannes C Kutten; Caitlin A Czajka; John C Sembrat; Mauricio Rojas; David Labrousse-Arias; Timothy N Bachman; Rebecca R Vanderpool; Brian S Zuckerbraun; Hunter C Champion; Ana L Mora; Adam C Straub; Richard A Bilonick; Maria J Calzada; Jeffrey S Isenberg
Journal:  Cardiovasc Res       Date:  2016-10-13       Impact factor: 10.787

8.  Organ-level right ventricular dysfunction with preserved Frank-Starling mechanism in a mouse model of pulmonary arterial hypertension.

Authors:  Zhijie Wang; Jitandrakumar R Patel; David A Schreier; Timothy A Hacker; Richard L Moss; Naomi C Chesler
Journal:  J Appl Physiol (1985)       Date:  2018-01-25

9.  Pulmonary vascular collagen content, not cross-linking, contributes to right ventricular pulsatile afterload and overload in early pulmonary hypertension.

Authors:  Zhijie Wang; David A Schreier; Hinnah Abid; Timothy A Hacker; Naomi C Chesler
Journal:  J Appl Physiol (1985)       Date:  2016-11-17

10.  Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension.

Authors:  Aiping Liu; David Schreier; Lian Tian; Jens C Eickhoff; Zhijie Wang; Timothy A Hacker; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-06-06       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.